INSIGHTA
LIVE

Serial Number

97886869

Owner

Insighta Limited

Attorney

PAUL E ROSSLER

Filing Date

Apr 13, 2023

Add to watchlist:

No watchlists yet
View on USPTO

INSIGHTA Trademark

Serial Number: 97886869 • Registration: 8007401

INSIGHTA is a trademark filed by Insighta Limited on April 13, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Insighta Limited

21st Floor
15 Queens Road Central , HK

Entity Type: 99

Trademark Details

Filing Date

April 13, 2023

Registration Date

November 4, 2025

Published for Opposition

April 1, 2025

Goods & Services

Apparatus for recording, transmission or reproduction of sound and images for data analysis of genetic and disease testing in the field of cancer screening and cancer detection; data processing equipment and computers for data analysis of genetic and disease testing in the field of cancer screening and cancer detection; computer systems comprised of hardware and downloadable computer hardware for the medical diagnostic instruments for data analysis of genetic and disease testing in the field of cancer screening and cancer detection; downloadable software for data analysis of genetic and disease testing and medical apparatus and instruments for detecting cancer; automated laboratory apparatus and computer systems, namely, nucleic acid extraction instruments and sequencers for use in analysis of biomolecules; nucleic acid sequencers for scientific purposes; downloadable computer software for data collection, management, and analysis of genetic information for use in the field of diagnostic and clinical research and for clinical diagnostic purposes and scientific research; downloadable computer software for use in database management in the field of data analysis for genetic and disease testing and for cancer screening and cancer detection; computer readable medical reports recorded on magnetic and optical media; biotechnology related software; namely, downloadable software for medical diagnostic software for data analysis of genetic and disease testing; DNA testing apparatus which carry or hold DNA samples, namely, nucleic acid extraction instruments and sequencers

Chemicals used in industry and science; assays and reagents for scientific and research use; diagnostic reagents and preparations for scientific use; chemical reagents for non-medical purposes; chemical reagents and kits containing same, each for scientific purposes; reagents, enzymes, and nucleotides for medical research use

Medical and veterinary preparations for use in medical and diagnostic purposes; medical diagnostic reagents; clinical diagnostic reagents for medical use; reagents, enzymes, and nucleotides for use in genetic testing for medical and medical diagnostic purposes; diagnostic tests and test kits consisting primarily of enzymes, buffer, nucleotides and magnetic beads for determination of genetic information for medical purposes; medical diagnostic test kits consisting primarily of enzymes, buffer, nucleotides and magnetic beads; diagnostic test kits consisting primarily of enzymes, buffer, nucleotides and magnetic beads for use in the fields of scientific and medical research, namely, for use in genetic and disease testing; diagnostic test kits consisting primarily of enzymes, buffer, nucleotides and magnetic beads for scientific use namely for use in genetic and disease testing; chemical test kits consisting primarily of enzymes, buffer, nucleotides and magnetic beads for scientific, clinical or medical laboratory use, namely, for use in genetic and disease testing

Scientific and technological services and research and design relating thereto, namely, design and development of testing for use in analysis of biomolecules relating to diagnosing or screening cancer and studying genetics and DNA; scientific research and development; medical research; design and development of computer hardware for sequencing of genetic materials used for genetic and disease testing and for cancer screening and cancer detection; design and development of computer software for analysis of genetic materials used for genetic and disease testing and cancer detection; DNA screening for scientific research purposes; providing reagent sample testing services for others in the fields of science and research related thereto; technical support services, namely, troubleshooting in the nature of diagnosing problems with medical equipment used for genetic and disease testing and for cancer screening and cancer detection; scientific consulting services in the field of genetic science and scientific research; providing online non-downloadable software for the custom design and ordering of assays and reagents; design and development of laboratory apparatus and instruments and computer systems for use in analysis of biomolecules; installation and maintenance of computer software and computer databases maintained on software used in the field of analysis of biomolecules for genetic and disease testing and for cancer screening and cancer detection; scientific consultancy, information and advisory services in the field of analysis of biomolecules; product development in the fields of scientific and clinical research; product research and development services for others in the field of chemicals and reagents for use as diagnostics, and other utilities, namely, analysis of biomolecules relating to diagnosing or screening cancer and studying genetics and DNA and chemical screening and diagnostic services for others; product research and development for others, and design for others, all in the field of pharmaceutical and health care products; laboratory research in the field of gene sequencing utilizing testing probes and analytic software; biotechnology research services; design and development of medical diagnostic apparatus and instruments and computer systems for use in analysis of biomolecules; chemical screening analysis, namely, drug screening for scientific purposes; research and development services for others in the field of chemicals and reagents for use as diagnostics, therapeutics, herbicides, cytotoxic agents, and other utilities, and chemical screening and diagnostic services for others; research, development and design of pharmaceutical and health care products; scientific research services, namely, gene sequencing services utilizing testing probes containing biochemical marker labels and analytic software; analyzing of nucleic acids and proteins, among which the analyzing of nucleic acids and proteins for detection purposes and monitoring, testing and approving the quality and specification of same; scientific and medical research; clinical diagnostic services for research purposes in preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids and other biological molecules from human beings and animals.

Surgical and medical apparatus and instruments for medical use; apparatus for use in medical analysis for analyzing body fluids and nucleic acid; cholesterol testing apparatus for medical diagnostic purposes; diagnostic apparatus for medical purposes for genetic and disease testing; electrophoresis apparatus for medical purposes; endoscopic equipment for medical purposes; enema apparatus for medical purposes; physical exercise apparatus for medical rehabilitative purposes; physical exercise footwear for medical rehabilitation purposes; gloves for medical purposes; magnetic resonance imaging apparatus for medical purposes; massage apparatus for medical purposes; medical apparatus and instruments for detecting cancer; imaging devices, namely, endoscopic equipment for medical purposes and magnetic resonance imaging apparatus for medical purposes; laboratory equipment, namely, incubators for medical purposes and medical diagnostic instruments for the analysis of body fluids; medical apparatus and instruments for detecting and treating cancer; scientific equipment and instruments, namely, medical diagnostic instruments for data analysis of genetic and disease testing; medical apparatus and instruments for detecting cancer

Medical services; veterinary services; hygienic and beauty care services for human beings and animals; medical diagnostic testing and reporting services; medical services, namely, analysis of biomolecules relating to diagnosing or screening cancer, diagnostic, forensic, namely, analysis of biomolecules relating to studying genetics and DNA and genetic medical testing services for others

Filing History

NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Mar 24, 2026 NURC
CORRECTION UNDER SECTION 7 - PROCESSED
Mar 4, 2026 COC.
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 23, 2026 APRE
TEAS SECTION 7 REQUEST RECEIVED
Nov 14, 2025 ES7R
POST PUBLICATION AMENDMENT REVIEWED – NO ACTION TAKEN
Nov 13, 2025 PPAD
ASSIGNED TO PETITION STAFF
Nov 12, 2025 APET
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 4, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 4, 2025 R.PR
ASSIGNED TO EXAMINER
Oct 22, 2025 DOCK
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Oct 9, 2025 ETOP
TEAS POST PUBLICATION AMENDMENT RECEIVED
Oct 1, 2025 EPPA
EXTENSION OF TIME TO OPPOSE RECEIVED
May 1, 2025 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 1, 2025 NPUB
PUBLISHED FOR OPPOSITION
Apr 1, 2025 PUBO
OPPOSITION TERMINATED NO. 999999
Mar 29, 2025 OP.T
OPPOSITION DISMISSED NO. 999999
Mar 29, 2025 OP.D
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 26, 2025 NONP
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Mar 11, 2025 JURT
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Mar 11, 2025 PCBG
ASSIGNED TO PETITION STAFF
Mar 10, 2025 APET
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Feb 7, 2025 ETOP
OPPOSITION INSTITUTED NO. 999999
Feb 7, 2025 OP.I
TEAS PETITION TO AMEND BASIS RECEIVED
Feb 6, 2025 TPAD
EXTENSION OF TIME TO OPPOSE RECEIVED
Sep 5, 2024 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 6, 2024 NPUB
PUBLISHED FOR OPPOSITION
Aug 6, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 17, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 1, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 26, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 26, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 26, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 10, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jun 10, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jun 10, 2024 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
May 16, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 16, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 16, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 8, 2024 GNRN
NON-FINAL ACTION E-MAILED
Apr 8, 2024 GNRT
NON-FINAL ACTION WRITTEN
Apr 8, 2024 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 12, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 12, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 12, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 16, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jan 16, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jan 16, 2024 CNRT
ASSIGNED TO EXAMINER
Jan 9, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 8, 2023 NWOS
NEW APPLICATION ENTERED
Apr 17, 2023 NWAP